NovaBridge Biosciences (NBP) Long-Term Investments (2020 - 2023)

NovaBridge Biosciences (NBP) has 4 years of Long-Term Investments data on file, last reported at $1.7 million in Q4 2023.

• Quarterly Long-Term Investments fell 61.31% year-over-year to $1.7 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.7 million (down 61.31% YoY) and the FY2022 annual result came in at $4.5 billion, up 7995.49% from the prior year.
• Long-Term Investments advanced to $1.7 million in Q4 2023 per NBP's latest filing, from $1.6 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $55.1 billion in Q4 2021 and bottomed at $40892.1 in Q4 2020.
• The 4-year median for Long-Term Investments is $18.4 million (2022), against an average of $6.9 billion.
• The widest annual swing landed in 2021, when Long-Term Investments soared 134678182.77%; it then plunged 99.99% in 2022.
• Tracing NBP's Long-Term Investments over 4 years: stood at $40892.1 in 2020, then soared by 134678182.77% to $55.1 billion in 2021, then sank by 99.99% to $4.3 million in 2022, then sank by 61.31% to $1.7 million in 2023.
• Per Business Quant, the three latest NBP Long-Term Investments figures stand at $1.7 million (Q4 2023), $1.6 million (Q2 2023), and $4.3 million (Q4 2022).

Peer Comparison